Smoking Treatment of Prisoners (STOP)

National Institutes of Health (NIH)

Status and phase: Completed; Phase 3

Conditions: Tobacco Use Cessation; Tobacco Use Disorder

Treatments: Behavioral: 10-week smoking cessation group therapy combined with NicoDerm CQ

Study type: Interventional

Funder types: Industry; NIH

Identifiers

NCT00110630

K23-15774-2

NIDA-15774-2

Details and patient eligibility

About

The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.

Full description

This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.

Enrollment: 250 patients

Sex: Female

Ages: 18 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 1. current smoker and (2) seeking group treatment to quit smoking.

Exclusion criteria

• (1) non-english speaking, (2) housed in segregation, (3) presence of active, severe mental illness as defined by active psychosis, manic episode, or imminently suicidal/homicidal, (4) mental retardation such that they cannot provide informed consent, and (5) due to be released or transferred to another facility within the next year.